Related Experiment Video
Updated: Oct 23, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Characteristics and Outcomes of COVID-19 Patients Admitted to Intensive Care Units in a Large Health System in
Adeel Nasrullah1, Thejus Jayakrishnan2, Patrick Wedgeworth2
1Pulmonary and Critical Care Medicine, Allegheny Health Network, Pittsburgh, USA.
Insights
This study found a high mortality rate of 32.8% in intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19) in Western Pennsylvania. Key predictors of mortality included age, comorbidities, and severity scores like APACHE.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Epidemiology
Background:
- Limited understanding of factors predicting outcomes for coronavirus disease 2019 (COVID-19) patients in intensive care units (ICUs).
- Scarcity of data on COVID-19 patient outcomes specifically within Pennsylvania.
Purpose of the Study:
- To evaluate the characteristics of COVID-19 patients admitted to the ICU.
- To identify factors associated with adverse outcomes in these patients.
- To determine predictors of inpatient mortality in COVID-19 ICU admissions.
Main Methods:
- Retrospective study of 58 COVID-19 patients admitted to ICUs in Western Pennsylvania between March 1, 2020, and April 30, 2020.
- Analysis included patient demographics, symptoms, comorbidities, vital signs, ICU complications, and interventions.
- Regression modeling was employed to identify predictors of inpatient mortality, with statistical significance set at P < 0.05.
Main Results:
- The cohort had a median age of 62 years, with 63.8% males; common symptoms included constitutional and lower respiratory tract issues.
- High rates of comorbidities (cardiovascular disease 74.1%, obesity 53.5%, diabetes 39.7%) and complications (ARDS 50.0%, shock 41.4%, AKI 41.4%) were observed.
- Overall inpatient mortality was 32.8%; significant mortality predictors included age, Charlson-comorbidity index, tachypnea, lymphopenia, high APACHE score, shock, ARDS, mechanical ventilation, and steroid use.
Conclusions:
- This study highlights a substantial inpatient mortality rate among COVID-19 patients requiring ICU care in Western Pennsylvania.
- Identifying prognostic factors is crucial for risk-stratifying critically ill COVID-19 patients.
- Further prospective research is warranted to assess the impact of early risk stratification and targeted interventions on patient outcomes.
Abstract:
Importance Despite growing literature, there is still limited understanding of factors that can predict outcomes in coronavirus disease 2019 (COVID-19) patients who require intensive care. Objective To evaluate the characteristics of COVID-19 patients admitted to the intensive care unit (ICU) and identify their associations with outcomes. Background There are limited data on the outcomes in COVID-19 patients in Pennsylvania. Design Retrospective study Setting Intensive care units in an academic health system in Western Pennsylvania. Participants Patients with reverse transcriptase-polymerase chain reaction (RT-PCR)-confirmed COVID-19 admitted to ICUs as direct admission or transfers from regular floors between March 1, 2020, and April 30, 2020. Main outcome(s) and measure(s) The primary outcome was inpatient mortality. Secondary outcomes included complications during ICU stay, hospital length of stay, discharge disposition, and the need for oxygen at discharge. Categorical variables are described as frequencies and continuous variables as median with interquartile range (IQR). Regression modeling was used to identify the predictors of inpatient mortality in these patients. P-value <0.05 was considered statistically significant. Analysis was performed using Stata version 15.1 (StataCorp, College Station, Texas). Results The cohort included 58 consecutive patients, with a median age of 62 years (IQR 54-73), 63.8% of which were male. On presentation, constitutional symptoms were the most common (91.4%), followed by lower respiratory tract symptoms (87.9%). Tachypnea (65.5%) and hypoxia (67.2%) were the most common abnormal vital signs at presentation. Common comorbidities were cardiovascular disease (74.1%), obesity (53.5%), and diabetes (39.7%). The median Acute Physiology and Chronic Health Evaluation (APACHE) score on admission to ICU was 11 (IQR 8.5-17.5). The major complications included acute respiratory distress syndrome (ARDS) 50.0%, shock 41.4%, and acute kidney injury 41.4%. The proportion of patients who underwent mechanical ventilation, required vasopressors, or were on renal replacement therapy were 58.6%, 41.4%, and 10.3%, respectively. Overall mortality was 32.8%. Age, Charlson-comorbidity index, tachypnea, lymphopenia at presentation, high APACHE score, shock, ARDS, mechanical ventilation, and steroid use were significantly associated with mortality. Of the patients who survived their ICU stay, 63.2% were discharged home and 44.7% had a new oxygen requirement at discharge. Conclusion and relevance Our study reports high mortality in COVID-19 patients requiring ICU care in Western Pennsylvania. Identifying factors associated with poor prognosis could help risk-stratify these patients. Prospective studies are needed to assess whether early risk stratification and triaging result in improved outcomes.
More Related Videos
07:16An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Acute Respiratory Failure-III
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: